Debbie L. Wilson

1.2k total citations
65 papers, 619 citations indexed

About

Debbie L. Wilson is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pharmacology. According to data from OpenAlex, Debbie L. Wilson has authored 65 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 16 papers in Epidemiology and 8 papers in Pharmacology. Recurrent topics in Debbie L. Wilson's work include Opioid Use Disorder Treatment (11 papers), Pharmaceutical Practices and Patient Outcomes (8 papers) and HIV, Drug Use, Sexual Risk (7 papers). Debbie L. Wilson is often cited by papers focused on Opioid Use Disorder Treatment (11 papers), Pharmaceutical Practices and Patient Outcomes (8 papers) and HIV, Drug Use, Sexual Risk (7 papers). Debbie L. Wilson collaborates with scholars based in United States, Taiwan and United Kingdom. Debbie L. Wilson's co-authors include Haesuk Park, Wei‐Hsuan Lo‐Ciganic, David B. Brushwood, Carole L. Kimberlin, Ching‐Yuan Chang, Daniel C. Malone, Hyun Jin Song, C. Kent Kwoh, Almut G. Winterstein and Kathryn Blake and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Debbie L. Wilson

59 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debbie L. Wilson United States	13	220	109	100	86	75	65	619
Sachin J. Shah United States	16	125 0.6×	115 1.1×	251 2.5×	71 0.8×	55 0.7×	55	757
Nai‐Wei Chen United States	13	106 0.5×	57 0.5×	93 0.9×	36 0.4×	27 0.4×	53	617
Jordan M. Harrison United States	13	132 0.6×	77 0.7×	155 1.6×	83 1.0×	18 0.2×	45	502
Geoffrey C. Lamb United States	12	209 0.9×	48 0.4×	157 1.6×	30 0.3×	29 0.4×	17	490
Kathleen A. Fairman United States	15	174 0.8×	69 0.6×	93 0.9×	32 0.4×	172 2.3×	56	963
Kelly C. Vranas United States	17	415 1.9×	89 0.8×	234 2.3×	156 1.8×	28 0.4×	50	1.0k
Daniela Vollenweider United States	14	329 1.5×	214 2.0×	146 1.5×	28 0.3×	37 0.5×	18	1.1k
James Harnett United States	18	92 0.4×	203 1.9×	105 1.1×	65 0.8×	34 0.5×	59	1.1k
Tanya Jackson Canada	9	188 0.9×	39 0.4×	52 0.5×	48 0.6×	15 0.2×	16	509
Satoshi Inoue Japan	13	374 1.7×	49 0.4×	66 0.7×	101 1.2×	11 0.1×	37	636

Countries citing papers authored by Debbie L. Wilson

Since Specialization

Citations

This map shows the geographic impact of Debbie L. Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie L. Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie L. Wilson more than expected).

Fields of papers citing papers by Debbie L. Wilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debbie L. Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie L. Wilson. The network helps show where Debbie L. Wilson may publish in the future.

Co-authorship network of co-authors of Debbie L. Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Debbie L. Wilson. A scholar is included among the top collaborators of Debbie L. Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debbie L. Wilson. Debbie L. Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Jingchuan, et al.. (2025). Suicide risk after abrupt discontinuation of long-term opioid therapy: an observational cohort study. Pain Medicine. 26(10). 631–642.

Bhattacharjee, Rakesh, Wei‐Hsuan Lo‐Ciganic, Debbie L. Wilson, et al.. (2025). Narcolepsy and risk of cardiovascular outcomes beyond stimulant use. SLEEP. 48(12). 1 indexed citations

Hong, Jung Hwa, Debbie L. Wilson, Khoa A. Nguyen, et al.. (2025). Protocol for a Single-Arm Pilot Clinical Trial: Developing and Evaluating a Machine Learning Opioid Prediction & Risk-Stratification E-Platform (DEMONSTRATE). Journal of Clinical Medicine. 14(23). 8522–8522.

Park, Haesuk, et al.. (2025). Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine. JAMA Neurology. 82(2). 132–132. 3 indexed citations

Noor‐E‐Alam, Md., Gary J. Young, Wei‐Hsuan Lo‐Ciganic, et al.. (2024). An explainable machine learning framework for predicting the risk of buprenorphine treatment discontinuation for opioid use disorder among commercially insured individuals. Computers in Biology and Medicine. 177. 108493–108493. 4 indexed citations

Yu, Zehao, Peng Cheng, Xi Yang, et al.. (2024). Identifying social determinants of health from clinical narratives: A study of performance, documentation ratio, and potential bias. Journal of Biomedical Informatics. 153. 104642–104642. 12 indexed citations

Militello, Laura G., Debbie L. Wilson, Khoa A. Nguyen, et al.. (2024). Using human factors methods to mitigate bias in artificial intelligence-based clinical decision support. Journal of the American Medical Informatics Association. 32(2). 398–403. 1 indexed citations

Nguyen, Khoa A., Debbie L. Wilson, Bradley R. Hall, et al.. (2024). Design and development of a machine-learning-driven opioid overdose risk prediction tool integrated in electronic health records in primary care settings. SHILAP Revista de lepidopterología. 10(1). 24–24. 2 indexed citations

Hernandez‐Con, Pilar, et al.. (2023). Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States. Journal of Managed Care & Specialty Pharmacy. 29(7). 721–731. 4 indexed citations

10.

Wang, Wei, et al.. (2023). Association between treatment of hepatitis C virus and risk of cardiovascular disease among insured patients with the virus in the United States. Pharmacoepidemiology and Drug Safety. 32(10). 1142–1151. 2 indexed citations

11.

Wang, Grace Hsin‐Min, et al.. (2023). Association between Antidepressants and Dementia Risk in Older Adults with Depression: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 12(19). 6342–6342. 10 indexed citations

12.

Guo, Jingchuan, Walid F. Gellad, Jeremy C. Weiss, et al.. (2022). Changes in predicted opioid overdose risk over time in a state Medicaid program: a group‐based trajectory modeling analysis. Addiction. 117(8). 2254–2263. 4 indexed citations

13.

Hincapie‐Castillo, Juan M., et al.. (2022). Trends in the Management of Headache Disorders in US Emergency Departments: Analysis of 2007–2018 National Hospital Ambulatory Medical Care Survey Data. Journal of Clinical Medicine. 11(5). 1401–1401. 15 indexed citations

14.

Song, Hyun Jin, et al.. (2022). A National Catalog of Mapped Short-Form Six-Dimension Utility Scores for Chronic Conditions in the United States From 2010 to 2015. Value in Health. 25(8). 1328–1335. 2 indexed citations

15.

Goodin, Amie, Debbie L. Wilson, Robert L. Cook, et al.. (2021). Proceedings of the 2021 Cannabis Clinical Outcomes Research Conference. SHILAP Revista de lepidopterología. 4(2). 143–146. 1 indexed citations

16.

Zhou, Lili, Sandipan Bhattacharjee, C. Kent Kwoh, et al.. (2021). Association Between Dual Trajectories of Opioid and Gabapentinoid Use and Healthcare Expenditures Among US Medicare Beneficiaries. Value in Health. 24(2). 196–205. 4 indexed citations

17.

Zhou, Lili, Sandipan Bhattacharjee, C. Kent Kwoh, et al.. (2020). Dual‐trajectories of opioid and gabapentinoid use and risk of subsequent drug overdose among Medicare beneficiaries in the United States: a retrospective cohort study. Addiction. 116(4). 819–830. 32 indexed citations

18.

Zhou, Lili, Sandipan Bhattacharjee, C. Kent Kwoh, et al.. (2019). Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016. Journal of Clinical Medicine. 9(1). 83–83. 37 indexed citations

19.

Wilson, Debbie L.. (2013). Pathways to Learning in Rett Syndrome.

20.

Wilson, Debbie L., Carole L. Kimberlin, David B. Brushwood, & Richard Segal. (2010). Investigation of the Potential Effects of Registration Requirements on Florida Pharmacy Technician Credentials. Journal of Pharmacy Technology. 26(3). 116–122. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact